Caxton Corporation’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Caxton Corporation’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,176	Closed	-$129K	–	15
2023 Q4	$129K	Buy	+13,176	New	+$104K	0.7%	10

Caxton Corporation's HARP Position: Q1 2024 in Review

Caxton Corporation sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 13,176 shares — an estimated $129K sold.

Caxton Corporation first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $129K in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Caxton Corporation reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Caxton Corporation sold 13,176 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $129K.
Caxton Corporation first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Caxton Corporation's Harpoon Therapeutics, Inc. Common Stock position peaked at $129K in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Caxton Corporation's 13F filing for Q1 2024, filed 15 May 2024.